Integra Lifesciences Holdings Corp
IART- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000917520
No open-market purchases or sales by Integra Lifesciences Holdings Corp insiders were filed in the last 90 days; 212 institutions reported holding it in 13F filings for Q2 2026, worth $1.32B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Integra Lifesciences Holdings Corp as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 285
- +13 vs. Q1 2022
- Shares held
- 73.1M
- −1.12M (−1.5%) vs. Q1 2022
- Total value
- $3.95B
- −$817.1M (−17.1%) vs. Q1 2022
- New holders
- 35
- 113 more added
- Sold out
- 22
- 96 more reduced
6 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IART on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 212 | $1.32B |
| Q1 2026 | 202 | $704.7M |
| Q4 2025 | 205 | $919.4M |
| Q3 2025 | 207 | $1.04B |
| Q2 2025 | 209 | $896.9M |
| Q1 2025 | 220 | $1.62B |
| Q4 2024 | 223 | $1.57B |
| Q3 2024 | 225 | $1.24B |
| Q2 2024 | 238 | $2.07B |
| Q1 2024 | 281 | $2.34B |
| Q4 2023 | 284 | $2.92B |
| Q3 2023 | 263 | $2.63B |
| Q2 2023 | 283 | $2.85B |
| Q1 2023 | 280 | $4.18B |
| Q4 2022 | 281 | $4.20B |
| Q3 2022 | 282 | $3.13B |
| Q2 2022 | 285 | $3.95B |
| Q1 2022 | 278 | $4.80B |
| Q4 2021 | 277 | $5.19B |
| Q3 2021 | 262 | $5.27B |
| Q2 2021 | 264 | $5.10B |
| Q1 2021 | 257 | $5.10B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Integra Lifesciences Holdings Corp; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −3,292−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −2,744−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Mascoma Wealth Management LLC | 0 | $0 | 0.00% | −148−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| Cordant, Inc. | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Fortitude Advisory Group L.L.C. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Teachers Retirement System of the State of Kentucky | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| SJS Investment Consulting Inc. | – | – | – | – | Not filed |